Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now includes a Results section with results posted (Results First Posted 2022-09-09) and related publications. This provides access to outcomes data.
    Difference
    0.2%
    Check dated 2025-11-03T12:35:11.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T17:27:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Added version tag v3.1.0 while removing several drug-safety and quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a narrowed content scope despite an updated version.
    Difference
    0.3%
    Check dated 2025-09-28T10:15:07.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:25:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-06T21:13:39.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as recent research studies related to pegbelfermin and its effects on liver diseases. Additionally, some previous location details and genetic resources have been removed.
    Difference
    6%
    Check dated 2025-08-30T15:34:40.000Z thumbnail image

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.